| 2025-05-14 16:27 | CC:CRDL | Cardiol Therapeutics Inc | 1.55 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-05-14 16:22 | CC:CRDL | Cardiol Therapeutics Inc | 1.55 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-04-29 15:28 | CC:CRDL | Cardiol Therapeutics Inc | 1.59 | News Release200 | Cardiol Therapeutics names Garnett as director nominee |
| 2025-04-16 16:45 | CC:CRDL | Cardiol Therapeutics Inc | 1.40 | News Release200 | Cardiol enrolls patient for phase 3 CardiolRx trial |
| 2025-04-01 07:28 | CC:CRDL | CARDIOL THERAPEUTICS INC. CL 'A' | 1.37 | News Release200 | Cardiol Therapeutics Announces Year-End 2024 Update on Operations |
| 2025-03-31 05:50 | CC:CRDL | Cardiol Therapeutics Inc | 1.37 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2025-03-31 05:45 | CC:CRDL | Cardiol Therapeutics Inc | 1.37 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-03-31 05:44 | CC:CRDL | Cardiol Therapeutics Inc | 1.37 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-02-20 16:20 | CC:CRDL | Cardiol Therapeutics Inc | 1.87 | News Release200 | Cardiol cheers cannabidiol research publication |
| 2025-02-04 07:28 | CC:CRDL | CARDIOL THERAPEUTICS INC. CL 'A' | 1.94 | News Release200 | Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference |
| 2024-11-18 18:06 | CC:CRDL | Cardiol Therapeutics Inc | 2.52 | News Release200 | Cardiol Therapeutics pleased with MAvERIC-Pilot results |
| 2024-11-14 17:01 | CC:CRDL | Cardiol Therapeutics Inc | 2.62 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-11-14 16:54 | CC:CRDL | Cardiol Therapeutics Inc | 2.62 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-11-13 13:43 | CC:CRDL | Cardiol Therapeutics Inc | 2.67 | News Release200 | Cardiol Therapeutics joins PRISM Emerging Biotech Index |
| 2024-10-22 12:58 | CC:CRDL | Cardiol Therapeutics Inc | 2.64 | News Release200 | Cardiol plans late-stage clinical trial for CardiolRx |
| 2024-10-11 13:28 | CC:CRDL | Cardiol Therapeutics Inc | 2.46 | News Release200 | Cardiol Therapeutics issues 1.26 M shares in greenshoe |
| 2024-10-10 16:40 | CC:CRDL | Cardiol Therapeutics Inc | 2.46 | News Release200 | Cardiol closes $13.5-million (U.S.) public offering |
| 2024-10-09 21:12 | CC:CRDL | Cardiol Therapeutics Inc | 2.53 | Prospectus Approved3 | Cardiol to list 8,437,500 more shares Oct. 10 |
| 2024-10-09 11:00 | CC:CRDL | Cardiol Therapeutics Inc | 2.69 | News Release200 | Cardiol Therapeutics prices $13.5M (U.S.) offering |
| 2024-10-08 17:58 | CC:CRDL | Cardiol Therapeutics Inc | 2.69 | News Release200 | Cardiol Therapeutics gets ready to make share offering |
| 2024-09-24 10:51 | CC:CRDL | Cardiol Therapeutics Inc | 3.12 | News Release200 | Cardiol hits target patient enrolment in Archer trial |
| 2024-09-10 15:12 | CC:CRDL | Cardiol Therapeutics Inc | 2.68 | News Release200 | Cardiol completes phase II study on CardiolRx |
| 2024-08-12 16:55 | CC:CRDL | Cardiol Therapeutics Inc | 2.77 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-08-12 16:55 | CC:CRDL | Cardiol Therapeutics Inc | 2.77 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-07-05 14:47 | CC:CRDL | Cardiol Therapeutics Inc | 2.70 | SEDAR Final Short Form Prospectus810 | SEDAR Final Short Form Prospectus |
| 2024-07-05 12:36 | CC:CRDL | Cardiol Therapeutics Inc | 2.70 | SEDAR Preliminary Short Form Prospectus819 | SEDAR Preliminary Short Form Prospectus |
| 2024-06-27 16:39 | CC:CRDL | Cardiol Therapeutics Inc | 2.74 | News Release200 | Cardiol Therapeutics holders approve AGM resolutions |
| 2024-06-25 11:37 | CC:CRDL | Cardiol Therapeutics Inc | 2.89 | News Release200 | Cardiol to webcast virtual AGSM June 26 |
| 2024-06-13 12:27 | CC:CRDL | Cardiol Therapeutics Inc | 4.07 | News Release200 | Cardiol Therapeutics reviews CardiolRx study data |